Silence Therapeutics Plc - ADR

XNAS: SLN

Weak Stock

Download real time

3.80 -0.10 (-2.56%)

New 52W Low today

273.2K XNAS Volume

XNAS 18 Mar, 2025 5:30 PM (EDT)

179.5

Market Cap

Below industry Median

0.1

Beta 1Year

Very Low volatility

Silence Therapeutics Plc - ADR - SLN - stock price prediction, stock price target, analyst ratings from 7 analysts

Silence Therapeutics Plc - ADR has a share price target of US$ 40, revenue growth forecast of -22.5%, and profit growth estimate of -141.9% for FY25, based on top 7 analyst calls.

Forecaster Screeners